Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Nonalcoholic Fatty Liver clinical trials
4 of 8 indexed Nonalcoholic Fatty Liver trials are currently recruiting.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 4 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Nonalcoholic Fatty Liver: 8 US clinical trials tracked, 4 recruiting.
Nonalcoholic Fatty Liver is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Target PharmaSolutions, running 1 of these trials.
Enrollment posture brief
Registry condition nonalcoholic-fatty-liver
OPEN 4 | RECR 50% | LATE 0 | EARLY 0 | RANK #2176 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Nonalcoholic Fatty Liver lists 4 open slots (50% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Nonalcoholic Fatty Liver on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Nonalcoholic Fatty Liver is recruiting above its size-band peers.
4 of 8 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Nonalcoholic Fatty Liver trials is spread across many organizations.
Target PharmaSolutions accounts for 1 of 8 trials (12.5%). 8 distinct sponsors appear on at least one study for this condition label.
-
Typical Nonalcoholic Fatty Liver enrolment sits around 100 participants.
Median target enrolment is 100 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.
-
Nonalcoholic Fatty Liver splits between interventional and observational designs.
5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Target PharmaSolutions
NCT02815891
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
Stanford University
NCT05165706
Metabolic Pathology of Pediatric NAFLD
University of Oklahoma
NCT05430178
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
Bettina Mittendorfer
NCT06335771
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Joslin Diabetes Center
NCT04595474
Weight, Energy, Lipids, and the Liver (WELL) Study
Ohio State University
NCT05199948
Accurate Point of Care Liver Disease Diagnostics
University of California, San Diego
NCT05986916
Feasibility of VIIT in Adults With NASH
Duke University
NCT03861819
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Nonalcoholic Fatty Liver records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Nonalcoholic Fatty Liver trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Nonalcoholic Fatty Liver page
8 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 4 Nonalcoholic Fatty Liver trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Target PharmaSolutions sponsors the most Nonalcoholic Fatty Liver trials on record, review their full trial history before evaluating a specific study. See Target PharmaSolutions's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nonalcoholic Fatty Liver condition card totals 8 registered trials; most-linked intervention Vigorous-intensity interval training (VIIT); top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.